IRIS
FORNARO, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.668
AS - Asia 1.106
EU - Europa 988
SA - Sud America 265
AF - Africa 55
OC - Oceania 4
Totale 4.086
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.611
SG - Singapore 574
BR - Brasile 227
RU - Federazione Russa 193
DE - Germania 182
CN - Cina 167
IT - Italia 160
SE - Svezia 137
HK - Hong Kong 135
FI - Finlandia 105
VN - Vietnam 69
GB - Regno Unito 62
FR - Francia 54
CA - Canada 39
IN - India 33
CI - Costa d'Avorio 27
JP - Giappone 22
BD - Bangladesh 19
AR - Argentina 18
PL - Polonia 17
ZA - Sudafrica 16
ID - Indonesia 15
MX - Messico 15
BE - Belgio 14
AT - Austria 13
NL - Olanda 11
PH - Filippine 11
TR - Turchia 11
IQ - Iraq 10
LT - Lituania 9
CZ - Repubblica Ceca 7
EC - Ecuador 7
IR - Iran 7
PK - Pakistan 6
UA - Ucraina 6
AM - Armenia 5
ES - Italia 5
UZ - Uzbekistan 5
AU - Australia 4
PY - Paraguay 4
TN - Tunisia 4
VE - Venezuela 4
CH - Svizzera 3
KE - Kenya 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
EE - Estonia 2
EG - Egitto 2
IE - Irlanda 2
KG - Kirghizistan 2
KR - Corea 2
KZ - Kazakistan 2
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
GF - Guiana Francese 1
JM - Giamaica 1
MA - Marocco 1
MK - Macedonia 1
MR - Mauritania 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
TL - Timor Orientale 1
TW - Taiwan 1
UY - Uruguay 1
Totale 4.086
Salva come PNG Salva come JPEG
Città #
Singapore 318
Ashburn 294
Chandler 170
Munich 138
Hong Kong 135
Fairfield 114
Nyköping 114
Beijing 89
Helsinki 69
Dallas 57
Houston 54
Cambridge 50
Los Angeles 50
New York 48
Woodbridge 43
Moscow 41
Seattle 40
Wilmington 36
Abidjan 27
Ann Arbor 27
Bari 27
Lawrence 26
Ho Chi Minh City 24
São Paulo 22
Turku 22
Buffalo 20
Roxbury 18
Inglewood 17
Santa Clara 17
Tokyo 16
Warsaw 15
Brussels 14
Frankfurt am Main 14
London 14
Toronto 14
Chicago 13
Des Moines 13
Hanoi 13
Milan 12
Poplar 12
Johannesburg 11
Montreal 11
Brooklyn 10
Denver 10
Stockholm 10
Florence 9
Jakarta 9
Phoenix 9
Princeton 9
Bacolod City 8
Jyväskylä 8
Mexico City 8
Paris 8
Pescara 8
Chennai 7
Manchester 7
San Francisco 7
Boardman 6
Boston 6
Council Bluffs 6
Dhaka 6
Falkenstein 6
Mumbai 6
Redwood City 6
Rio de Janeiro 6
Salt Lake City 6
Amsterdam 5
Belo Horizonte 5
Düsseldorf 5
Illkirch-Graffenstaden 5
Modugno 5
Naples 5
Orem 5
Ottawa 5
Porto Alegre 5
Pune 5
Shanghai 5
Tashkent 5
Vienna 5
Yerevan 5
Ankara 4
Bengaluru 4
Brno 4
Campinas 4
Columbus 4
Dong Ket 4
Dongguan 4
Fulham 4
Nanjing 4
Nuremberg 4
Pittsburgh 4
San Diego 4
Trani 4
Antalya 3
Brasília 3
Brescia 3
Bắc Ninh 3
Grottaglie 3
Haiphong 3
Hebei 3
Totale 2.603
Salva come PNG Salva come JPEG
Nome #
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 208
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 163
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 157
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 144
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 138
Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis 130
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 127
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 125
AB0245 PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE) 110
Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy 98
Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings 96
Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort 93
Sindrome anti-sintetasi: due casi di anti-EJ (anti-glycyl-tRNAsintetasi) 91
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment 91
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients 88
Body mass index and adipokines/cytokines dysregulation in systemic sclerosis 88
Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis 82
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus 80
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 79
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry 79
Cartilage damage: clinical approach 79
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors 78
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients 76
Complete Hydatidiform Mole Mimicking Sacroiliitis 76
Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance 76
Effectiveness and safety of secukinumab in patients with moderate-severe psoriasis: A multicenter real-life study 73
Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis 70
Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis 69
Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering 67
Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection 66
Effectiveness of Tapering Rituximab Dose in Idiopathic Inflammatory Myopathies: Real-World Data from a Monocentric Study 66
Phosphorylated signal transducer and activator of transcription 3 (pSTAT3) is highly expressed in CD14+ circulating cells of scleroderma patients 65
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents 61
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity 60
Preliminary data on post market safety profiles of covid 19 vaccines in rheumatic diseases: Assessments on various vaccines in use, different rheumatic disease subtypes, and immunosuppressive therapies: A two-centers study 59
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis 59
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 57
Anti-SARS-CoV-2 antibody decay after vaccination and immunogenicity of the booster dose of the BNT162b2 mRNA vaccine in patients with psoriatic arthritis on TNF inhibitors 55
Histopathologic Features of Fibrotic Knee Synovitis in a Young Adult with Seronegative Rheumatoid Arthritis 55
Effectiveness of biological targeted therapies may discriminate seronegative from seropositive rheumatoid arthritis 54
Letters to the editors 52
Prevalence and management of tuberculosis infection in Apulian rheumatologic patients treated with biologics: An observational cohort 10-year study from the BIOPURE registry 50
Erratum: Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus (Rheumatology (2020) 59 (1188) DOI: 10.1093/rheumatology/kez442) 50
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 46
Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registry 42
Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre 42
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases 41
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 40
The impact of multimorbidity on QoL in inflammatory myopathies: COVAD cluster analysis 40
Subcutaneous immunoglobulin therapy for refractory skin thickening in rapidly progressive systemic sclerosis: A case report and literature review 36
Paradoxical Pustular Psoriasis in a Patient with Psoriatic Arthritis on Secukinumab Treatment 36
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study 36
Predictors of long-term clinical remission in rheumatoid arthritis 27
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registry 23
Mobile session fixation attack in micropayment systems 23
Integrating large language models in medicine: a study of Claude 2’s performance in MDAAT scoring for idiopathic inflammatory myopathies 19
Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study 16
Rituximab-induced hypogammaglobulinaemia in patients affected by idiopathic inflammatory myopathies: a multicentre study 15
Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies 15
Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the biologic apulian registry (BIOPURE) 14
Relapses of idiopathic inflammatory myopathies after vaccination against COVID-19: a real-life multicenter Italian study 13
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 10
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registry 10
Response to: ‘Response to: “Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients” by Fornaro et al‘ by Agca et al 8
Neuropathic pain in spondyloarthritis: Decoding its prevalence, risk factors, and impact on disease activity 8
Turning the Tide against Herpes Zoster in Rheumatoid Arthritis Patients Treated with JAK Inhibitors 3
Totale 4.303
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.845
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.845
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021142 0 0 0 0 0 15 22 23 22 19 31 10
2021/2022226 9 2 5 10 9 11 25 14 17 30 32 62
2022/2023455 46 76 30 31 30 69 9 66 61 6 19 12
2023/2024221 17 45 13 19 13 41 9 6 3 7 3 45
2024/20251.364 42 13 62 26 25 136 188 247 65 95 174 291
2025/20261.563 388 151 218 350 415 41 0 0 0 0 0 0
Totale 4.303